Skip to main content
. 2012 Oct 25;7:5565–5575. doi: 10.2147/IJN.S36939

Figure 9.

Figure 9

Dissolution profiles of raw fenofibrate, the commercial product (Lipidi Supra®), and prepared powders in 0.025 M sodium lauryl sulfate.

Notes: (A) Dissolution profiles related to the weight ratio of fenofibrate/Neusilin UFL2 using supercritical method (SC). (B) Dissolution profiles from raw fenofibrate, the commercial product, and powders prepared using various adsorption methods. Data are expressed as the mean ± standard deviation (n = 3).

Abbreviations: HME, hot-melt adsorption method; SE, solvent evaporation method; SC1, supercritical method 1 (Fenofibrate:Neusilin UFL2 = 67:33); SC2, supercritical method 2 (Fenofibrate:Neusilin UFL2 = 50:50); SC3, supercritical method 3 (Fenofibrate:Neusilin UFL2 = 40:60); SC4, supercritical method 4 (Fenofibrate:Neusilin UFL2 = 33:67).